Top list · Wilmington
Biotech startups in Wilmington
10 biotech startups in Wilmington have raised money in rounds we track. These are the 10 that have raised the most, $559M between them.
- 1
TraceLinkTraceLink is a leading digital network platform that specializes in the orchestration of the pharmaceutical and life sciences supply chain.TraceLink is a leading digital network platform that specializes in the orchestration of the pharmaceutical and life sciences supply chain.
Founded 2009Wilmington, United States$174Mlast round Aug 2018 - 2
Prelude TherapeuticsPrelude Therapeutics designs and develops small molecule therapies targeting key drivers of cancer cell growth and resistance.Prelude Therapeutics designs and develops small molecule therapies targeting key drivers of cancer cell growth and resistance.
Founded 2016Wilmington, United States$150Mlast round Apr 2026 - 3
Synnovation TherapeuticsSynnovation Therapeutics is a clinical-stage biotechnology company based in Wilmington, Delaware, founded in 2021.Synnovation Therapeutics is a clinical-stage biotechnology company based in Wilmington, Delaware, founded in 2021.
Founded 2021Wilmington, United States$102Mlast round Dec 2023 - 4
TruverisTruveris is a healthcare technology company founded in 2009, based in Wilmington, Delaware, with additional offices in New York.Truveris is a healthcare technology company founded in 2009, based in Wilmington, Delaware, with additional offices in New York.
Founded 2009Wilmington, United States$67Mlast round May 2024 - 5
Converge BioConverge Bio integrates Generative AI with biological data.Converge Bio integrates Generative AI with biological data.
Founded -Wilmington, United States$31Mlast round Jan 2026 - 6
Topography HealthTopography Health is a clinical trials technology company with locations in New York and Los Angeles.Topography Health is a clinical trials technology company with locations in New York and Los Angeles.
Founded 2020Wilmington, United States$22Mlast round Jan 2022 - 7
HyféHyfe is a leader in AI-powered cough-monitoring and respiratory care technology, based in Wilmington, Delaware.Hyfe is a leader in AI-powered cough-monitoring and respiratory care technology, based in Wilmington, Delaware.
Founded 2020Wilmington, United States$9.0Mlast round Jun 2023 - 8
iQure PharmaiQure Pharma is a global biotech company that develops new therapeutics for patients and physicians.iQure Pharma is a global biotech company that develops new therapeutics for patients and physicians.
Founded 2019Wilmington, United States$4.3Mlast round Sept 2026 - 9
Altera BiosciencesAltera Biosciences is a biotechnology company based in South Africa, focused on developing a universal donor cell platform.Altera Biosciences is a biotechnology company based in South Africa, focused on developing a universal donor cell platform.
Founded -Wilmington, United States$1.6Mlast round Jul 2025 - 10
Solace LifesciencesSolace Lifesciences is a neuroscience company and innovator in solving chronic stress at the midbrain level.Solace Lifesciences is a neuroscience company and innovator in solving chronic stress at the midbrain level.
Founded 2002Wilmington, United States$50Klast round Sept 2010
Wilmington, United StatesCompanies whose funding rounds we classed in this sector, ranked by the total they have raised in rounds we hold. Nobody pays to be on a list.
Who backed them?
Open any company for its rounds and investors, or search the investors who back biotech startups in Wilmington in the app, with filters, lists and exports.
More biotech lists
See all
IL
NH
CSBiotech startups in Europe1,665 companies · $22B
GVIL
RMBiotech startups that raised in 2026896 companies · $37B in 2026ILCS
ONBiotech startups in the United Kingdom588 companies · $15BGVRM
MBiotech startups in the United States that raised in 2026498 companies · $32B in 2026NH
DT
EBiotech startups founded in 2018368 companies · $14BNR
LL
STBiotech startups founded in 2020337 companies · $7.0B
E
NABiotech startups founded in 2019336 companies · $11BIL
RB
VSBiotech startups founded in 2021275 companies · $12B
N
CA
BE
V
L
M
CS
R
K
WL
GT
A